Private Payer Coverage Policies for ApoE-e4 Genetic Testing

PURPOSE: ApoE-e4 has a well-established connection to late-onset Alzheimer’s disease (AD) and is available clinically. Yet, there have been no analyses of payer coverage policies for ApoE. Our objective is to analyze private payer coverage policies for ApoE genetic testing, examine the rationales, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias, Jalayne J., Tyler, Ana M., Douglas, Michael P., Phillips, Kathryn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035237/
https://www.ncbi.nlm.nih.gov/pubmed/33420342
http://dx.doi.org/10.1038/s41436-020-01042-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035237/
https://www.ncbi.nlm.nih.gov/pubmed/33420342
http://dx.doi.org/10.1038/s41436-020-01042-4

Ejemplares similares